Vertex Pharmaceuticals Incorporated shares owned by Martingale Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Martingale Asset Management
from 13F filings
Historical chart of Martingale Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Martingale Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $29M | 63k | 468.72 |
| 2024-03-31 | $29M | 70k | 418.01 |
| 2023-12-31 | $31M | 77k | 406.89 |
| 2023-09-30 | $28M | 81k | 347.74 |
| 2023-06-30 | $29M | 82k | 351.91 |
| 2023-03-31 | $26M | 84k | 315.07 |
| 2022-12-31 | $24M | 83k | 288.78 |
| 2022-09-30 | $25M | 86k | 289.54 |
| 2022-06-30 | $19M | 66k | 281.79 |
| 2022-03-31 | $14M | 53k | 260.99 |
| 2021-12-31 | $2.4M | 11k | 219.62 |
| 2021-09-30 | $968k | 5.3k | 181.55 |
| 2021-06-30 | $17M | 86k | 201.64 |
| 2021-03-31 | $23M | 105k | 214.89 |
| 2020-12-31 | $16M | 68k | 236.35 |
| 2020-09-30 | $35M | 128k | 272.12 |
| 2020-06-30 | $25M | 86k | 290.32 |
| 2020-03-31 | $3.5M | 15k | 237.97 |
| 2019-12-31 | $1.1M | 5.2k | 219.05 |
| 2019-09-30 | $1.9M | 11k | 169.45 |
| 2019-06-30 | $2.5M | 14k | 183.45 |
| 2019-03-31 | $2.5M | 14k | 183.96 |
| 2018-12-31 | $2.3M | 14k | 165.75 |
| 2018-09-30 | $2.7M | 14k | 192.76 |
| 2018-06-30 | $1.9M | 11k | 170.00 |
| 2018-03-31 | $2.1M | 13k | 163.04 |
| 2017-12-31 | $2.1M | 14k | 149.86 |
| 2017-09-30 | $2.2M | 14k | 152.04 |
| 2017-06-30 | $1.3M | 9.8k | 128.91 |
| 2017-03-31 | $1.0M | 9.5k | 109.40 |
More positions owned by Martingale Asset Management
View all positions for Martingale Asset Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated